Cargando…

Percutaneous coronary intervention in patients with cancer using bare metal stents compared to drug-eluting stents

BACKGROUND: Management of coronary artery disease (CAD) is unique and challenging in cancer patients. However, little is known about the outcomes of using BMS or DES in these patients. This study aimed to compare the outcomes of percutaneous coronary intervention (PCI) in cancer patients who were tr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ahmed, Talha, Pacha, Homam Moussa, Addoumieh, Antoine, Koutroumpakis, Efstratios, Song, Juhee, Charitakis, Konstantinos, Boudoulas, Konstantinos Dean, Cilingiroglu, Mehmet, Marmagkiolis, Konstantinos, Grines, Cindy, Iliescu, Cezar A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9626509/ https://www.ncbi.nlm.nih.gov/pubmed/36337872 http://dx.doi.org/10.3389/fcvm.2022.901431

Ejemplares similares

2021. The year in review. Structural heart interventions
por: Marmagkiolis, Konstantinos, et al.
Publicado: (2022)

TAVR in Cancer Patients: Comprehensive Review, Meta-Analysis, and Meta-Regression
por: Marmagkiolis, Konstantinos, et al.
Publicado: (2021)

Stress cardiomyopathy in hospitalized patients with cancer: machine learning analysis by primary malignancy type
por: Javaid, Awad I., et al.
Publicado: (2021)

Percutaneous Muscular Ventricular Septal Defect Closure with 2D Transthoracic Echocardiography: Can We Sufficiently Visualize It?
por: Mutlu, Deniz, et al.
Publicado: (2021)

Mid-Term Follow-Up of Drug-Eluting Stenting for In-Stent Restenosis: Bare-Metal Stents versus Drug-Eluting Stents
por: Faramarzi, Negar, et al.
Publicado: (2013)

Predictors of Recurrence and Survival in Cancer Patients With Pericardial Effusion Requiring Pericardiocentesis
por: Ahmed, Talha, et al.
Publicado: (2022)

Cost-effectiveness of drug-eluting stents versus bare-metal stents in patients undergoing percutaneous coronary intervention
por: Baschet, Louise, et al.
Publicado: (2016)

Radiation-Induced Vascular Disease—A State-of-the-Art Review
por: Yang, Eric H., et al.
Publicado: (2021)

Comparison of drug-eluting and bare metal stents for extracranial vertebral artery stenting
por: Maciejewski, Damian R., et al.
Publicado: (2019)

Percutaneous Coronary Intervention in Patients With Gynecological Cancer: Machine Learning-Augmented Propensity Score Mortality and Cost Analysis for 383,760 Patients
por: Thomason, Nicole, et al.
Publicado: (2022)

Machine Learning-Augmented Propensity Score Analysis of Percutaneous Coronary Intervention in Over 30 Million Cancer and Non-cancer Patients
por: Monlezun, Dominique J., et al.
Publicado: (2021)

Identification of independent risk factors for restenosis following bare-metal stent implantation: Role of bare-metal stents in the era of drug-eluting stents
por: PARK, CHANG-BUM, et al.
Publicado: (2013)

Outcomes of stenting with overlapping drug-eluting stents versus overlapping drug-eluting and bare-metal stents for the treatment of diffuse coronary lesions
por: Kassaian, SE, et al.
Publicado: (2010)

Comparison of bare metal stent and paclitaxel-eluting stent using a novel rat aorta stent model
por: Kwon, Jin Sook, et al.
Publicado: (2011)

Percutaneous coronary intervention with second-generation drug-eluting stent versus bare-metal stent: Systematic review and cost–benefit analysis
por: Poder, Thomas G., et al.
Publicado: (2017)

Lesion Length Impacts Long Term Outcomes of Drug-Eluting Stents and Bare Metal Stents Differently
por: Chang, Shang-Hung, et al.
Publicado: (2013)

Identification of functional modules induced by bare-metal stents and paclitaxel-eluting stents in coronary heart disease
por: Tang, Zhaobin, et al.
Publicado: (2018)

Vascular Responses to First-Generation Sirolimus-Eluting Stents and Bare-Metal Stents Beyond 10 Years
por: Hada, Masahiro, et al.
Publicado: (2021)

Exploring alternatives to drug-eluting stents: the potential of combining drug coated balloon with bare-metal stents
por: Murai, Kota, et al.
Publicado: (2023)

Long-term outcomes of intravascular ultrasound-guided implantation of bare metal stents versus drug-eluting stents in primary percutaneous coronary intervention
por: Cho, Yun-Kyeong, et al.
Publicado: (2014)

Comparison of Drug-eluting Coronary Stents, Bare Coronary Stents and Self-expanding Stents in Angioplasty of Middle Cerebral Artery Stenoses
por: Lee, Jong-Hyeog, et al.
Publicado: (2013)

Stent thrombosis rates the first year and beyond with new- and old-generation drug-eluting stents compared to bare metal stents
por: Varenhorst, Christoph, et al.
Publicado: (2018)

COVID-19 COMPLICATED BY RESPIRATORY FAILURE INCREASES INPATIENT STEMI MORTALITY: MACHINE LEARNING-AUGMENTED MODIFIED PROPENSITY SCORE ADJUSTED LONGITUDINAL COHORT STUDY
por: Ynalvez, Leslie Ammabel, et al.
Publicado: (2023)

Bare metal stents, durable polymer drug eluting stents, and biodegradable polymer drug eluting stents for coronary artery disease: mixed treatment comparison meta-analysis
por: Bangalore, Sripal, et al.
Publicado: (2013)

Spectral Analysis Related to Bare-Metal and Drug-Eluting Coronary Stent Implantation
por: da Silva, Rose Mary Ferreira Lisboa, et al.
Publicado: (2014)

Long-term clinical outcomes of drug-eluting stents vs. bare-metal stents in Chinese geriatric patients
por: Chan, Pak-Hei, et al.
Publicado: (2013)

Stent implantation into the tracheo-bronchial system in rabbits: histopathologic sequelae in bare metal vs. drug-eluting stents
por: Sigler, Matthias, et al.
Publicado: (2015)

Efficacy and safety of sirolimus-eluting stents versus bare-metal stents in coronary artery disease patients with diabetes
por: Jing, Juehua
Publicado: (2014)

The effects of bare metal versus drug-eluting stent implantation on circulating endothelial cells following percutaneous coronary intervention(*)
por: Jazi, Seyed Mohammad Hashemi, et al.
Publicado: (2011)

Coronary Stent Healing in Cancer Patients—An Optical Coherence Tomography Perspective
por: Aziz, Moez Karim, et al.
Publicado: (2021)

Comparison of outcome in 1809 patients treated with drug-eluting stents or bare-metal stents in a real-world setting
por: Vogt, Alexander, et al.
Publicado: (2011)

Effectiveness of Drug-Eluting Stents versus Bare-Metal Stents in Large Coronary Arteries in Patients with Acute Myocardial Infarction
por: Sim, Doo Sun, et al.
Publicado: (2011)

Comparison of the Efficacy of Drug-eluting Stents Versus Bare-metal Stents for the Treatment of Left Main Coronary Artery Disease
por: Wang, Xiao-Zeng, et al.
Publicado: (2015)

Nine-year clinical outcomes of drug-eluting stents vs. bare metal stents for large coronary vessel lesions
por: Yin, Dong, et al.
Publicado: (2017)

Effect of a Drug-Eluting Stent vs. Bare Metal Stent for the Treatment of Symptomatic Intracranial and Vertebral Artery Stenosis
por: Si, Jiang-Hua, et al.
Publicado: (2022)

Drug-eluting stents appear superior to bare metal stents for vein-graft PCI in vessels up to a stent diameter of 4 mm
por: Guttmann, Oliver P., et al.
Publicado: (2016)

Clinical Outcomes of Drug-Eluting versus Bare-Metal In-Stent Restenosis after the Treatment of Drug-Eluting Stent or Drug-Eluting Balloon: A Systematic Review and Meta-Analysis
por: Yang, Yi-Xing, et al.
Publicado: (2020)

Neointimal coverage of bare-metal and sirolimus-eluting stents evaluated with optical coherence tomography
por: Chen, B X, et al.
Publicado: (2008)

Early bare-metal stent thrombosis presenting with cardiogenic shock: a case report
por: Lampropoulos, Konstantinos M, et al.
Publicado: (2011)

Clinical results of everolimus-eluting stents and sirolimus-eluting stents in patients undergoing percutaneous coronary intervention
por: Jafaripour, Iraj, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_cqsfm2rrsga15rr3v35241f259